Novartis shares dropped around 5% after it reported fourth-quarter earnings and sales that missed consensus expectations and issued guidance that analysts said fell short of hopes.
Source link
Novartis shares dropped around 5% after it reported fourth-quarter earnings and sales that missed consensus expectations and issued guidance that analysts said fell short of hopes.
Source link
